Dr. Joseph Mercola - Take Control of Your Health Berberine and Diabetes — How It Works, What the Studies Show, and Safe Dosing
9 snips
Feb 4, 2026 Discussion covers how berberine activates AMPK to boost glucose uptake and fat burning. A large meta-analysis showing reductions in fasting glucose and A1c is highlighted. Trials reporting improved lipids, reduced liver fat, and kidney‑protection markers are reviewed. Practical dosing strategies, tolerability issues, and safety cautions for specific populations are also covered.
AI Snips
Chapters
Transcript
Episode notes
AMPK Activation Explains Broad Metabolic Effects
- Berberine activates AMPK, increasing cellular glucose uptake and shifting fuel use toward fat burning.
- This explains concurrent reductions in liver glucose production, inflammation, and oxidative stress.
Meta‑Analysis Shows Meaningful Glucose Reductions
- A 2022 meta-analysis of 37 randomized trials found berberine lowered fasting glucose by 0.82 mmol/L and HbA1c by 0.63%.
- The effect was consistent across diverse patient groups with a favorable short-term safety profile.
Lipid And Liver Benefits Alongside Glucose Control
- Trials also reported large improvements in lipids and reduced hepatic fat in fatty liver patients.
- Berberine acts as an alpha-glucosidase inhibitor, blunting post-meal glucose spikes.